Jinxia Liu, Xiangrong Chen, Tian-zao Huang, B. Dong, Yuxing Cai
{"title":"肠内免疫营养补充ω-3多不饱和脂肪酸对重型颅脑损伤患者呼吸机治疗中呼吸机相关性肺炎并发症发生率的影响","authors":"Jinxia Liu, Xiangrong Chen, Tian-zao Huang, B. Dong, Yuxing Cai","doi":"10.3760/CMA.J.ISSN.1674-635X.2018.05.002","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid (ω-3 PUFA) on the incidences and severity of ventilator associated pneumonia complications, inflammatory response, and the prognosis in patients with severe traumatic brain injury(sTBI)undergoing ventilator therapy. \n \n \nMethods \nFrom January 2015 to June 2017, 64 patients of sTBI were selected and randomly divided into experimental group (ω-3 PUFA, n=32) and control group(n=32). White blood cells (WBC) and the proportion of neutrophils (N%) were evaluated by cell analyzer. Meanwhile, the serum levels of C-reactive protein (CRP) and procalcitonin (PCT) were tested with enzyme linked immunosorbent assay. After 14-days treatment, the Glasgow coma scale (GCS) score, APACHE Ⅱ score, clinical pulmonary infection score (CPIS), pulmonary function and prognoses were also compared between the two groups. \n \n \nResults \nAs compared with the control group, the experimental group had lower incidences of ventilator associated pneumonia(66% vs.56%, P=0.048), reduced degree of lung infection and lower CPIS(8.25±0.60 vs.7.47±0.53); higher lung function indexes[FVC: (2.89±0.19)L vs.(3.46±0.22)L, P=0.010; FEV1: (2.35±0.16)L vs.(2.84±0.24)L, P=0.040; FEV1/FVC %: (49.11±3.34)% vs.(56.00±2.64)%, P=0.038)]; lower serum levels of inflammatory responses [WBC: (11.83±0.74)×109/L vs.(9.51±0.90)×109/L, P=0.029; N%: (79.11±1.51)% vs.(72.71±1.16)%, P=0.041; CRP: (85.15±8.42)mg/L vs.(63.96±5.72)mg/L, P=0.001; PCT: (6.43±0.47)μg/L vs.(4.83±0.39)μg/L, P=0.013]14 days after enteral immunonutrition supplemented with ω-3 PUFA. As compared with the control group, the experimental group received better prognosis with GCS scores increasing(8.69±0.41 vs.9.52±0.59, P=0.038), APACHE Ⅱ scores decreasing(14.74±1.01 vs.12.68±0.89, P=0.049), the time of mechanical ventilation [(13.23±1.17)d vs.(10.88±1.24)d, P=0.024] and the hospitalization days [(23.29±2.45)d vs.(18.42±1.96)d, P=0.012] reduced on the 14th day, mechanical ventilation withdraw rate within 14 days increasing [24/32 (75%) vs.27/32(84%), P=0.030] on the 14th day. \n \n \nConclusion \nEnteral immunonutrition supplemented with ω-3 PUFA can effectively reduce the incidence of ventilator associated pneumonia, alleviate the degree of infection and the inflammatory response in patients with sTBI undergoing ventilator therapy possibly improving condition and prognosis, which is worthy of being widely used. \n \n \nKey words: \nCraniocerebral trauma; Unsaturated fatty acid; Ventilator associated pneumonia; Inflammatory response","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":"26 1","pages":"267-271"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid on the incidences of ventilator associated pneumonia complications in patients with severe traumatic brain injury undergoing ventilator therapy\",\"authors\":\"Jinxia Liu, Xiangrong Chen, Tian-zao Huang, B. Dong, Yuxing Cai\",\"doi\":\"10.3760/CMA.J.ISSN.1674-635X.2018.05.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo investigate the effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid (ω-3 PUFA) on the incidences and severity of ventilator associated pneumonia complications, inflammatory response, and the prognosis in patients with severe traumatic brain injury(sTBI)undergoing ventilator therapy. \\n \\n \\nMethods \\nFrom January 2015 to June 2017, 64 patients of sTBI were selected and randomly divided into experimental group (ω-3 PUFA, n=32) and control group(n=32). White blood cells (WBC) and the proportion of neutrophils (N%) were evaluated by cell analyzer. Meanwhile, the serum levels of C-reactive protein (CRP) and procalcitonin (PCT) were tested with enzyme linked immunosorbent assay. After 14-days treatment, the Glasgow coma scale (GCS) score, APACHE Ⅱ score, clinical pulmonary infection score (CPIS), pulmonary function and prognoses were also compared between the two groups. \\n \\n \\nResults \\nAs compared with the control group, the experimental group had lower incidences of ventilator associated pneumonia(66% vs.56%, P=0.048), reduced degree of lung infection and lower CPIS(8.25±0.60 vs.7.47±0.53); higher lung function indexes[FVC: (2.89±0.19)L vs.(3.46±0.22)L, P=0.010; FEV1: (2.35±0.16)L vs.(2.84±0.24)L, P=0.040; FEV1/FVC %: (49.11±3.34)% vs.(56.00±2.64)%, P=0.038)]; lower serum levels of inflammatory responses [WBC: (11.83±0.74)×109/L vs.(9.51±0.90)×109/L, P=0.029; N%: (79.11±1.51)% vs.(72.71±1.16)%, P=0.041; CRP: (85.15±8.42)mg/L vs.(63.96±5.72)mg/L, P=0.001; PCT: (6.43±0.47)μg/L vs.(4.83±0.39)μg/L, P=0.013]14 days after enteral immunonutrition supplemented with ω-3 PUFA. As compared with the control group, the experimental group received better prognosis with GCS scores increasing(8.69±0.41 vs.9.52±0.59, P=0.038), APACHE Ⅱ scores decreasing(14.74±1.01 vs.12.68±0.89, P=0.049), the time of mechanical ventilation [(13.23±1.17)d vs.(10.88±1.24)d, P=0.024] and the hospitalization days [(23.29±2.45)d vs.(18.42±1.96)d, P=0.012] reduced on the 14th day, mechanical ventilation withdraw rate within 14 days increasing [24/32 (75%) vs.27/32(84%), P=0.030] on the 14th day. \\n \\n \\nConclusion \\nEnteral immunonutrition supplemented with ω-3 PUFA can effectively reduce the incidence of ventilator associated pneumonia, alleviate the degree of infection and the inflammatory response in patients with sTBI undergoing ventilator therapy possibly improving condition and prognosis, which is worthy of being widely used. \\n \\n \\nKey words: \\nCraniocerebral trauma; Unsaturated fatty acid; Ventilator associated pneumonia; Inflammatory response\",\"PeriodicalId\":9877,\"journal\":{\"name\":\"中华临床营养杂志\",\"volume\":\"26 1\",\"pages\":\"267-271\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华临床营养杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2018.05.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2018.05.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
Effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid on the incidences of ventilator associated pneumonia complications in patients with severe traumatic brain injury undergoing ventilator therapy
Objective
To investigate the effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid (ω-3 PUFA) on the incidences and severity of ventilator associated pneumonia complications, inflammatory response, and the prognosis in patients with severe traumatic brain injury(sTBI)undergoing ventilator therapy.
Methods
From January 2015 to June 2017, 64 patients of sTBI were selected and randomly divided into experimental group (ω-3 PUFA, n=32) and control group(n=32). White blood cells (WBC) and the proportion of neutrophils (N%) were evaluated by cell analyzer. Meanwhile, the serum levels of C-reactive protein (CRP) and procalcitonin (PCT) were tested with enzyme linked immunosorbent assay. After 14-days treatment, the Glasgow coma scale (GCS) score, APACHE Ⅱ score, clinical pulmonary infection score (CPIS), pulmonary function and prognoses were also compared between the two groups.
Results
As compared with the control group, the experimental group had lower incidences of ventilator associated pneumonia(66% vs.56%, P=0.048), reduced degree of lung infection and lower CPIS(8.25±0.60 vs.7.47±0.53); higher lung function indexes[FVC: (2.89±0.19)L vs.(3.46±0.22)L, P=0.010; FEV1: (2.35±0.16)L vs.(2.84±0.24)L, P=0.040; FEV1/FVC %: (49.11±3.34)% vs.(56.00±2.64)%, P=0.038)]; lower serum levels of inflammatory responses [WBC: (11.83±0.74)×109/L vs.(9.51±0.90)×109/L, P=0.029; N%: (79.11±1.51)% vs.(72.71±1.16)%, P=0.041; CRP: (85.15±8.42)mg/L vs.(63.96±5.72)mg/L, P=0.001; PCT: (6.43±0.47)μg/L vs.(4.83±0.39)μg/L, P=0.013]14 days after enteral immunonutrition supplemented with ω-3 PUFA. As compared with the control group, the experimental group received better prognosis with GCS scores increasing(8.69±0.41 vs.9.52±0.59, P=0.038), APACHE Ⅱ scores decreasing(14.74±1.01 vs.12.68±0.89, P=0.049), the time of mechanical ventilation [(13.23±1.17)d vs.(10.88±1.24)d, P=0.024] and the hospitalization days [(23.29±2.45)d vs.(18.42±1.96)d, P=0.012] reduced on the 14th day, mechanical ventilation withdraw rate within 14 days increasing [24/32 (75%) vs.27/32(84%), P=0.030] on the 14th day.
Conclusion
Enteral immunonutrition supplemented with ω-3 PUFA can effectively reduce the incidence of ventilator associated pneumonia, alleviate the degree of infection and the inflammatory response in patients with sTBI undergoing ventilator therapy possibly improving condition and prognosis, which is worthy of being widely used.
Key words:
Craniocerebral trauma; Unsaturated fatty acid; Ventilator associated pneumonia; Inflammatory response
期刊介绍:
The Chinese Journal of Clinical Nutrition was founded in 1993. It is the first professional academic journal (bimonthly) in my country co-sponsored by the Chinese Medical Association and the Chinese Academy of Medical Sciences to disseminate information on clinical nutrition support, nutrient metabolism, the impact of nutrition support on outcomes and "cost-effectiveness", as well as translational medicine and nutrition research. It is also a professional journal of the Chinese Medical Association's Parenteral and Enteral Nutrition Branch.
The purpose of the Chinese Journal of Clinical Nutrition is to promote the rapid dissemination of knowledge on nutrient metabolism and the rational application of parenteral and enteral nutrition, focusing on the combination of multidisciplinary and multi-regional field investigations and clinical research. It mainly reports on nutritional risk screening related to the indications of parenteral and enteral nutrition support, "cost-effectiveness" research on nutritional drugs, consensus on clinical nutrition, guidelines, expert reviews, randomized controlled studies, cohort studies, glycoprotein and other nutrient metabolism research, systematic evaluation of clinical research, evidence-based case reports, special reviews, case reports and clinical experience exchanges, etc., and has a special column on new technologies related to the field of clinical nutrition and their clinical applications.